Osaic Holdings
AVBP icon

Osaic Holdings’s ArriVent BioPharma AVBP Stock Holding History

Osaic Holdings’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Buy
702
+106
+18% +$2.39K ﹤0.01% 5997
2025
Q4 		$12K Buy
596
+118
+25% +$2.46K ﹤0.01% 6225
2025
Q3 		$8.82K Buy
478
+309
+183% +$6.07K ﹤0.01% 6443
2025
Q2 		$3.38K Buy
+169
New +$3.51K ﹤0.01% 6746
2025
Q1 		– Sell
-17
Closed -$453 – 7743
2024
Q4 		$453 Buy
+17
New +$488 ﹤0.01% 7039

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings's AVBP Position: Q1 2026 in Review

Osaic Holdings increased its ArriVent BioPharma (AVBP) stake by 18% in Q1 2026, buying an estimated $2.39K and bringing the position to 702 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5997.

Osaic Holdings first reported a position in AVBP in Q4 2024 and has held it in 5 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Osaic Holdings held 702 shares of ArriVent BioPharma worth $16.2K as of Q1 2026.
  • Osaic Holdings bought 106 ArriVent BioPharma shares in Q1 2026, an estimated $2.39K.
  • ArriVent BioPharma made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5997 holding.
  • Osaic Holdings first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 5 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.